Maxipime/Piperacillin Combo Trial Kit from Canada
Clinical trial kit with piperacillin/tazobactam vials for double-blind studies on resistant infections. Still under HTS 3004.10.50.48 as measured-dose therapeutic medicaments, though chapter notes reference blinded kits in 3006. Specific combo dictates 3004 classification.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• IND exemption letter from FDA; declare as 'investigational use only'
• Secure chain of custody for blinded materials; IRB approval docs
• Avoid retail classification pitfalls by specifying trial context